Nurix (NRIX) PT Lowered to $30 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NRIX Hot Sheet
Price: $25.82 --0%
Rating Summary:
20 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Rating Summary:
20 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 12
Join SI Premium – FREE
JPMorgan analyst Eric Joseph lowered the price target on Nurix (NASDAQ: NRIX) to $30.00 (from $36.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Nurix (NRIX) PT Lowered to $20 at Wells Fargo
- Sanofi drops STAT6 degrader program in Nurix collaboration
- Amgen (AMGN) PT Raised to $400 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
